KG (King Pharmaceuticals) Happy New Year to all, Pete Earle Paolo Pezzutti enters: If I may humbly add my 2 cents: - bearish on S&P: 900 in dec - crisis in Europe will bring EURUSD down to 1.15 - gold will remain a safe have haven: up to 1500 - big winner: natural gas to ...
LegoChem Biosciences, a Kosdaq-listed drug development company, said Tuesday that it signed a technology transfer agreement with Janssen Pharmaceuticals, a pharmaceutical company wholly owned by Johnson & Johnson, for the development and commercialization of LCB84, antibody-drug conjugate (ADC) candidate...
Filed Under: Clinical Trials, Drug-Device Combinations, Neurological, Pharmaceutical, Wall Street Beat Tagged With: Janssen Pharmaceuticals, Johnson and Johnson More recent news InspireMD submits carotid stent for FDA premarket approval Penumbra wins CE mark for computer-assisted thrombectomy tech ...
/PRNewswire/ -- Johnson & Johnson (NYSE:JNJ) today announced it has entered into a definitive agreement to acquire Momenta Pharmaceuticals, Inc. (Momenta), a...
while in the former case only one is substituted. A minimal D.S. is especially preferred when γ-CD is used as solubilizer of pharmaceuticals for use in parenteral applications, while a higher D.S. is preferred when used in technical applications, such as, for example, for pesticides or ...
US 2001/034343; U.S. Pat. No. 6,211,199; U.S. Pat. No. 6,194,406; WO 97/22604 and WO 97/19074 are a number of patent applications filed by Aventis Pharmaceuticals Inc. providing 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic diseases. In these ...